CANCER CELLS GENE ISOLATED/NEW VACCINE OR ANTIBODIES FOR TREATMENT POSSIBLE

CANCER IS THE MOST DANF\GEROUS DISEASE OF MANKIND,NEW RESEARCH IDENTIFYING A COMMON GENE FOR ALL CANCER IS A GREAT INVENTION,NOW MORE SPECIFIC ANTIBODIES AND AN EFFECTIVE VACCINE AGAINST CANCER MAY BE DEVELOPED .
TWO GREAT RESEARCH FOR FIGHTING CANCER :

Half of all cancers caused by a single gene: Study
Cancerous is still the notorious disease killing thousands every year and burdening a great load on patient ,health structure,pharmacy and on treating Doctors.We have conquered good control of many cancers by amixing of Radiotherapy,chemotherapy and surgery,almost a relief or palliation is possible in all cases but such treatment very painful for all patients physically and economically as an individual or family or society or nation as more and more effective and costly cancer medicines has been added,more correct surgical operation with Robot and laproscopy beside open surgery is possible,a galaxy of radiotherapy tools like linear accelator,cobalt therapy,ct guided or pet guided IMRT, cyclotron RT and gamma kninef,cyber knife etc has opened a ray of hope for cancer patients but still this new study has added that more than half of all cancerous tumours are associated with defects in a single gene.
Cancer is abnormal growth or proliferation of cells where a check on their growth is inhibited resulting excess growth and more cells occupy a small area they damage this area and spread to another are or organ and then spread by blood or lymphatics to Body’s other distant part and one day they block all vital organs and functions making us bleedor infected or death.

The researchers hope that the new findings can lead to new strategies for targeting cancer through genetic manipulation.

A team of cancer scientists - from the University of Cincinnati, Bellvitge Biomedical Research Institute, and Catalan Oncology Institute - said they have determined how the so-called p53 gene acts as a tumour-suppressing gene to protect healthy cells and prevent the development of abnormal cancerous cells.Researchers believe that the gene produces proteins that can either repair damaged cells or cause tumour cells to die.But when the gene is not working properly, due to a defect or mutation, the proteins that repair cells or target tumours are not produced, and the cancer grows.The new study, led by George Thomas, identified the molecular processes that regulate the stability of p53 to keep the gene functioning properly to keep cancer cells in check.

The results suggest genetics play a significant role in cancer development and point the way to potential new treatments based on that the emerging scientific understanding of how tumours grow and spread.Thomas said understanding how p53 is regulated and function is critical as "more than 50 percent of tumours have mutations in p53."

.

Human trial for wonder drug to fight cancer to start in 2014
Stanford researchers are on track to begin human trials of a potentially potent new drug against cancer by next year, it has been revealed.The progress comes just two months after the groundbreaking study by Dr Irv Weissman, who developed an antibody that breaks down a cancer`s defense mechanisms in the body, the New York Post reported.

A protein called CD47 tells the body not to "eat" the cancer, but the antibody developed by Dr Weissman blocks CD47 and frees up immune cells called macrophages - which can then engulf the deadly cells.The new research shows the miraculous macrophages effectively act as intelligence gatherers for the body, pointing out cancerous cells to cancer-fighting "killer T" cells.

The T cells then "learn" to hunt down and attack the cancer, the researchers claimed.The clinical implications of the process could be profound in the war on cancer.When macrophages present "killer T" cells with a patient`s cancer, the T cells become attuned to the unique molecular markers on the cancer.This turns them into a personalized cancer vaccine.

Like ·  · Unfollow Post · Share · Promote